Wetzel Investment Advisors, Inc. Dexcom Inc Transaction History
Wetzel Investment Advisors, Inc.
- $176 Million
- Q1 2024
A detailed history of Wetzel Investment Advisors, Inc. transactions in Dexcom Inc stock. As of the latest transaction made, Wetzel Investment Advisors, Inc. holds 883 shares of DXCM stock, worth $56,512. This represents 0.07% of its overall portfolio holdings.
Number of Shares
883
Previous 26
3296.15%
Holding current value
$56,512
Previous $3,000
3966.67%
% of portfolio
0.07%
Previous 0.0%
Shares
2 transactions
Others Institutions Holding DXCM
# of Institutions
1,125Shares Held
353MCall Options Held
4.19MPut Options Held
4.54M-
Vanguard Group Inc Valley Forge, PA44.6MShares$2.85 Billion0.12% of portfolio
-
Black Rock Inc. New York, NY33.9MShares$2.17 Billion0.11% of portfolio
-
State Street Corp Boston, MA16.2MShares$1.04 Billion0.1% of portfolio
-
Baillie Gifford & CO15.3MShares$981 Million1.38% of portfolio
-
Capital Research Global Investors Los Angeles, CA13.4MShares$860 Million0.43% of portfolio
About DEXCOM INC
- Ticker DXCM
- Exchange NASDAQ
- Sector Healthcare
- Industry Medical Devices
- Shares Outstandng 386,257,984
- Market Cap $24.7B
- Description
- DexCom, Inc., a medical device company, focuses on the design, development, and commercialization of continuous glucose monitoring (CGM) systems in the United States and internationally. The company provides its systems for use by people with diabetes, as well as for use by healthcare providers. Its products include DexCom G6, an integrated CGM ...